2019
DOI: 10.1016/j.celrep.2019.04.070
|View full text |Cite
|
Sign up to set email alerts
|

PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism

Abstract: SUMMARY Insulin stimulates the conversion of phosphatidylino-sitol-4,5-bisphosphate (PI(4,5)P 2 ) to phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P 3 ), which mediates downstream cellular responses. PI(4,5)P 2 is produced by phosphatidylinositol-4-phosphate 5-kinases (PIP5Ks) and by phosphatidylinositol-5-phos-phate 4-kinases (PIP4Ks). Here, we show that the loss of PIP4Ks ( PIP4K2A, PIP4K2B , and … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
39
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 39 publications
(48 citation statements)
references
References 48 publications
(76 reference statements)
8
39
0
Order By: Relevance
“…Results from such samples using our assay could help decipher signalling mechanisms in human tumours and help inform decision making in clinical oncology. Finally, PIP4K a key enzyme in the regulation of PI5P levels has been recently implicated in the control of insulin receptor signalling and Type II diabetes [23,35,36]. The mechanisms by which PIP4K regulates insulin signalling remain unclear but the use of our assay on human samples of small size and high value could help in the study of the role of this enzyme and its control of PI5P levels in human type II diabetes settings.…”
Section: Discussionmentioning
confidence: 99%
“…Results from such samples using our assay could help decipher signalling mechanisms in human tumours and help inform decision making in clinical oncology. Finally, PIP4K a key enzyme in the regulation of PI5P levels has been recently implicated in the control of insulin receptor signalling and Type II diabetes [23,35,36]. The mechanisms by which PIP4K regulates insulin signalling remain unclear but the use of our assay on human samples of small size and high value could help in the study of the role of this enzyme and its control of PI5P levels in human type II diabetes settings.…”
Section: Discussionmentioning
confidence: 99%
“…Results from such samples using our assay could help decipher signalling mechanisms in human tumours and help inform decision making in clinical oncology. Finally, PIP4K a key enzyme in the regulation of PI5P levels has been recently implicated in the control of insulin receptor signalling and Type II diabetes [23,34,35]. The mechanisms by which PIP4K regulates insulin signalling remain unclear but the use of our assay on human samples of small size and high value could help in the study of the role of this enzyme and its control of PI5P levels in human type II diabetes settings.…”
Section: Discussionmentioning
confidence: 99%
“…It is also noteworthy that several genetic susceptibility loci in PI5P4Kγ have been linked to autoimmune diseases, including rheumatoid arthritis and type 1 diabetes mellitus, and that PI5P4Kγdeficient mice exhibit a hyperimmune phenotype (Barton et al, 2008;Fung et al, 2009;Shim et al, 2016 (Shim et al, 2016). Such upregulation of S6-Kinase activity may be explained by the role of PI5P4Kγ in inhibiting PI4P5K activity and downstream PI 3-kinase activity (Wang et al, 2019). Therefore, PI5P4Kα and PI5P4Kβ kinase activity The localization of PI5P4Kα and PI5P4Kβ to the perisynaptic region continues to support the role of the PI5P4Ks in intracellular PI-4,5-P 2 pathways (Clarke et al, 2009).…”
Section: Regional and Cell Type-specific Expression Of Pi5p4kα And mentioning
confidence: 99%